Proposal
FDA proposal would allow N-acetyl-L-cysteine to be sold as a dietary supplement
The FDA proposes allowing N-acetyl-L-cysteine (NAC) to be sold legally as a dietary supplement.
If you manufacture or sell dietary supplements containing N-acetyl-L-cysteine (NAC), this proposal concerns you. The FDA wants to change the rules so that NAC is no longer excluded from the legal definition of a dietary supplement. If this rule is finalized, products containing NAC could be lawfully marketed as supplements, provided they meet all other safety and labeling requirements.
What to do: If you wish to influence this decision, you must submit electronic or written comments to the FDA by January 19, 2027.
What we do not know: how this change will affect specific product labeling requirements or how the FDA will monitor compliance once the rule is in force. This is currently a proposal and not yet a final law.
Headlines and summaries are written by AI for Outer News (RS Elite Pro s.r.o.) from the official text and are not reviewed by a person. They are not the official text and can contain mistakes: before you rely on one, read the original.
Original title: Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition
Read the official decisionSource: Federal Register · Public domain